153 related articles for article (PubMed ID: 1830754)
1. Transient myeloproliferative disorder in Down's syndrome: three cases with megakaryocytic markers.
Sartori PC; Darbyshire PJ
Pediatr Hematol Oncol; 1991; 8(2):139-45. PubMed ID: 1830754
[TBL] [Abstract][Full Text] [Related]
2. Megakaryoblastic leukemia and Down's syndrome: a review.
Zipursky A; Peeters M; Poon A
Pediatr Hematol Oncol; 1987; 4(3):211-30. PubMed ID: 2978961
[TBL] [Abstract][Full Text] [Related]
3. Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome.
Ito E; Kasai M; Hayashi Y; Toki T; Arai K; Yokoyama S; Kato K; Tachibana N; Yamamoto M; Yokoyama M
Br J Haematol; 1995 Jul; 90(3):607-14. PubMed ID: 7647001
[TBL] [Abstract][Full Text] [Related]
4. Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report.
Prabhu PD; V G; Niveditha SR; Gayathri BR; Keshavamurthy SR
Indian J Pathol Microbiol; 2004 Jan; 47(1):48-50. PubMed ID: 15471129
[TBL] [Abstract][Full Text] [Related]
5. Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.
Malinge S; Izraeli S; Crispino JD
Blood; 2009 Mar; 113(12):2619-28. PubMed ID: 19139078
[TBL] [Abstract][Full Text] [Related]
6. Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia").
Slørdahl SH; Smeland EB; Holte H; Grønn M; Lie SO; Seip M
Med Pediatr Oncol; 1993; 21(4):254-8. PubMed ID: 8469219
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megakaryoblastic leukaemia in Down's syndrome.
Eguchi M; Sakaibara H; Suda J; Ozawa T; Hayashi Y; Sato T; Kojima S; Furukawa T
Br J Haematol; 1989 Nov; 73(3):315-22. PubMed ID: 2532535
[TBL] [Abstract][Full Text] [Related]
8. Transient abnormal myelopoiesis in Down's syndrome.
Kurahashi H; Hara J; Yumura-Yagi K; Tawa A; Kawa-Ha K
Leuk Lymphoma; 1992 Dec; 8(6):465-75. PubMed ID: 1297480
[TBL] [Abstract][Full Text] [Related]
9. Acute megakaryoblastic leukemia and severe pulmonary fibrosis in a child with Down syndrome: successful treatment with ultra low-dose cytarabine using GATA1 mutation to monitor minimal residual disease.
Moritake H; Yamada A; Kimoto Y; Sawa D; Shimonodan H; Nunoi H
Am J Hematol; 2012 Apr; 87(4):447-50. PubMed ID: 22389016
[No Abstract] [Full Text] [Related]
10. Leukemia with Down's syndrome: translocation between chromosomes 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome.
Morgan R; Hecht F; Cleary ML; Sklar J; Link MP
Blood; 1985 Dec; 66(6):1466-8. PubMed ID: 2415189
[TBL] [Abstract][Full Text] [Related]
11. Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without Down syndrome.
Brissette MD; Duval-Arnould BJ; Gordon BG; Cotelingam JD
Am J Hematol; 1994 Dec; 47(4):316-9. PubMed ID: 7977305
[TBL] [Abstract][Full Text] [Related]
12. A newborn with Down syndrome-transient myeloproliferative disorder.
Akdag A; Tunç B; Oğuz S; Dilli D; Dilmen U
J Perinat Med; 2010 Jul; 38(4):445-7. PubMed ID: 20443668
[No Abstract] [Full Text] [Related]
13. Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome.
Kanegane H; Watanabe S; Nomura K; Xu G; Ito E; Miyawaki T
Int J Hematol; 2007 Oct; 86(3):250-2. PubMed ID: 17988992
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome.
Zipursky A; Thorner P; De Harven E; Christensen H; Doyle J
Leuk Res; 1994 Mar; 18(3):163-71. PubMed ID: 8139285
[TBL] [Abstract][Full Text] [Related]
15. Acute megakaryoblastic leukemia in Down syndrome.
Hitzler JK
Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
[TBL] [Abstract][Full Text] [Related]
16. Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.
Simon JH; Tebbi CK; Freeman AI; Brecher ML; Green DM; Sandberg AA
Cancer; 1987 Nov; 60(10):2515-20. PubMed ID: 2959356
[TBL] [Abstract][Full Text] [Related]
17. Prominent megakaryocytic dysplasia after regression of transient abnormal myelopoiesis associated with GATA-1 mutation.
Anoop P; Atra A
J Pediatr Hematol Oncol; 2012 Nov; 34(8):640. PubMed ID: 23007419
[TBL] [Abstract][Full Text] [Related]
18. [GATA1 analysis in myeloproliferative disorders associated to trisomy 21].
Fuster Soler JL; Norton A; Galera Miñarro A; Bermúdez Cortés M; Llinares Riestra ME; Ortuño Giner F
An Pediatr (Barc); 2011 Jan; 74(1):31-7. PubMed ID: 20870473
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis of transient myeloproliferative disorder via percutaneous umbilical blood sampling. Report of two cases in fetuses affected by Down's syndrome.
Foucar K; Friedman K; Llewellyn A; McConnell T; Aisenbrey G; Argubright K; Ballinger L
Am J Clin Pathol; 1992 Apr; 97(4):584-90. PubMed ID: 1532471
[TBL] [Abstract][Full Text] [Related]
20. Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction.
Kojima S; Matsuyama T; Sato T; Horibe K; Konishi S; Tsuchida M; Hayashi Y; Kigasawa H; Akiyama Y; Okamura J
Blood; 1990 Dec; 76(11):2348-53. PubMed ID: 2147864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]